Login to Your Account



Ketamine shown to act as antidepressant by boosting serotonin

By John Fox
Staff Writer

Wednesday, January 22, 2014

HONG KONG – The results of a positron emission tomography (PET) molecular imaging study in monkeys suggest that the anesthetic, ketamine, may help in the diagnosis of major depressive disorder in humans and development of new antidepressants, report Japanese researchers from the Riken Center for Life Science Technologies.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription